IASIS and PTSD:
What does research show?
IASIS Microcurrent Neurofeedback (MCN) is an evidence-informed intervention shown to significantly reduce symptoms of anxiety, depression, and PTSD. It works by increasing parasympathetic tone—stimulating the release of calming neurochemicals like GABA, serotonin, dopamine, and endorphins—while reducing stress-related neurochemicals such as cortisol and noradrenaline, which are often elevated after trauma. Simultaneously, IASIS MCN activates the cholinergic system, enhancing acetylcholine regulation and supporting memory and neural plasticity through microglial activation.
Microglia, which outnumber neurons 9 to 1, play a crucial role in clearing excess beta-amyloid and other metabolic waste, improving overall brain function. These changes begin within minutes of a session. A University of Texas study demonstrated that participants experienced over a 50% reduction in symptoms related to anxiety, depression, and PTSD.
IASIS with Opioids addiction and recovery
Anyone who takes an opioid, legal or illegal, is at risk of becoming addicted. Why? Opioids work on your brain in a manner that is different from all other addictive substances. Opioids target your brain's neurotransmitters and become substitute endorphins that mimic your body’s natural endorphins like dopamine and serotonin. Over time, your brain slows the natural production of endorphins. At this point, addicts feel they must take drugs in order to experience normal feelings of happiness, pleasure, fun, or normal day-to-day emotions.
Instead of drug therapy, a highly effective microcurrent neurofeedback technology called IASIS permits patients and their therapists to literally reboot the brain. Many MDs and licensed clinicians are now using IASIS in their offices to treat a range of neurological and behavioral issues, including opioid addiction, other addictions, mTBI, PTSD, ADD, ADHD, anxiety, autism, depression, migraines, pain, and many others.